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CD200 is a cell surface glycoprotein that binds an inhibitory receptor (CD200R) on myeloid cells. 
CD200 orthologues are present in many species of virus, and we show that the rat cytomegalovirus 
CD200 orthologue (e127) is expressed at the cell surface on infected cells. It binds the host CD200R 
with the same affinity as that of the host protein, and thus this protein acts as a close mimic of the host 
protein and has the potential to downregulate immune responses to the virus.  
 
 
The Herpesviridae and Poxviridae have large genomes with more than 100 open reading frames 
(ORFs). A number of these have been acquired from their hosts and are involved in subverting the 
immune system (6, 13). These include CD200-like sequences that have been identified in many 
viruses, including gammaherpesviruses (human herpesvirus 8 [HHV-8]), betaherpesviruses (HHV-6, 
HHV-7, and the English isolate of rat cytomegalovirus [RCMV-E]), poxviruses (Yaba-like disease virus 
and myxoma virus), and duck adenovirus (see references 5 and 16). CD200 is a membrane protein 
containing two IgSF (immunoglobulin superfamily) domains expressed by many host cell types that 
interacts with a receptor, CD200R, that is highly expressed on myeloid cells and can mediate anti-
inflammatory signals (1, 2, 7, 8, 10, 11, 15, 17).  
The CD200 orthologues in HHV-6, HHV-7, and HHV-8 (14) have been shown to bind CD200R, and in 
one case the HHV-8 K14 protein has been shown to bind with the same kinetics as those of the host 
protein (5). The use of recombinant viral CD200 orthologues has indicated that these can give 
downregulatory signals to myeloid cells, including macrophages and basophils in vitro in HHV-8 (5, 14) 
and in rhesus rhadinovirus (9). The poxvirus orthologues show less similarity to the host than these 
herpesvirus orthologues, and they have only one IgSF domain. However, there are functional data for 
myxoma virus consistent with an interaction with the CD200R (4, 18). In this report, we identify 
CD200R as the receptor for the RCMV-E CD200 orthologue e127 (16). The latter protein binds the 
inhibitory CD200 receptor with the same affinity and kinetics as those of the host CD200 and is 
expressed during viral infection.  
The e127 ORF predicts a transmembrane protein with 56% amino acid sequence identity with rat 
CD200 (16). In order to characterize its receptor on host cells, a recombinant protein was constructed 
with the two IgSF domains of RCMV e127 coupled to CD4 domains 3 and 4 as an antigenic tag and a 
peptide sequence at the C terminus that allows biotinylation in vitro (e127CD4) (3). A comparable 
CD200CD4 protein had been used to identify the receptor for host CD200 by coupling the protein onto 
fluorescent beads (17). The e127CD4 beads bound rat peritoneal cells in a manner identical to that of 
host CD200CD4 beads, as shown by flow cytometry (Fig. 1). The receptor was confirmed as the 
CD200R, as binding of both reagents was blocked if the peritoneal cells were preincubated with 
monoclonal antibody (MAb) specific for CD200R (OX102) but not with an isotype-matched control (Fig. 
1). This indicates that the e127 ORF codes for a protein that binds the same receptor as that of host 
CD200, confirming that it is a structural orthologue of CD200 in addition to showing sequence 
similarity.  
A direct interaction between purified e127 and CD200R proteins was shown by surface plasmon 
resonance, and the affinity was determined by injecting a series of different concentrations of purified 
  
monomeric e127CD4 (Fig. 2, left) or rat CD200CD4 injected over immobilized rat CD200RCD4 (Fig. 2, 
right) and a negative control (CD4) in separate flow cells on a streptavidin-coated chip in a BIAcore 
2000 apparatus (BIAcore AB, St. Albans, United Kingdom) as described previously (17). The binding 
is represented by the difference in response units (RU) observed in the rat CD200R and control flow 
cells (Fig. 2A) once equilibrium has been reached. The equilibrium binding affinities (KD) were 
measured at 37°C and calculated by both nonlinear curve fitting of the Langmuir binding (Fig. 2B) and 
Scatchard transformations of the binding data (Fig. 2B, insets), giving similar values. The rat CD200 
and the e127 bound to rat CD200R with identical equilibrium binding affinities (KD of 1.5 μM at 37°C). 
Clearly, the kinetic parameters of this interaction are important and are mimicked in this virus and the 
orthologue in HHV-8 (5). There are data for binding to CD200R of other CD200 viral orthologues in 
rhadinovirus, HHV-6, and HHV-7 (5, 14).  
The molecular data point to a role for the e127 protein mimicking the host CD200 in giving a 
downregulatory signal to myeloid cells. To investigate if e127 is involved in downregulation of 
macrophage activity in vitro or in vivo, we constructed a mutant virus lacking the e127 ORF by 
inserting a lacZ gene flanked by LoxP sites into the e127 ORF in the RCMV wild type (RCMV wt) by 
homologous recombination in rat embryo fibroblast (REF) cells (Fig. 3A). Disruption of the e127 ORF 
was verified by Southern blot analysis (Fig. 3B, C) and sequencing. To repair the RCMVΔe127lacZ 
virus, virion DNA was cotransfected with the RCMV HindIII J fragment containing the e127 ORF (16), 
and the revertant virus (RCMVe127rev) was isolated. The RCMVΔe127lacZ-negative virus was 
generated by passage of the original mutant virus in REF cells expressing Cre recombinase as 
described previously (12), and the RCMVΔe127 virus was isolated with one LoxP site remaining (Fig. 
3 A). The replication abilities of the viruses were compared in single- and multistep growth 
experiments by infecting cells with a low multiplicity of infection (MOI) of 0.1 and a high MOI of 5, 
respectively. No significant differences of viral replication in cell culture could be detected at these two 
multiplicities of infection (Fig. 3D, E). This is consistent with a role for e127 subverting the immune 
response rather than affecting virus replication.  
If the e127 protein functions as a CD200 orthologue, then it should be expressed at the cell surface 
during infection. This was tested using the OX2 MAb that recognizes rat CD200 and cross-reacted on 
the e127 protein. Infection of REF cells that lack CD200 expression confirmed that e127 was 
expressed at the protein level during RCMV wt or RCMVe127rev infection but not with the virus in 
which e127 was deleted (Fig. 4A to D). In contrast to RCMV wt infection in REF cells, e127 could not 
be detected on the surface after infection of the rat macrophage cell line NR8383 (Fig. 4E), and virus 
spread was inefficient among macrophages (Fig. 4F).  
The possibility that e127 caused downregulation of inflammatory responses was tested by measuring 
inducible nitric oxide synthase (iNOS) and tumor necrosis factor alpha (TNF-α) production from 
activated macrophages by cell-cell contact with cells expressing e127. To test this, an assay was 
devised to culture the macrophage cell line NR8383 in the presence of REF cells expressing viral 
e127 and then monitor macrophage activity by TNF-α and iNOS production. REF cells were infected 
with the RCMV wt, RCMVΔe127, and RCMVe127rev viruses. After 24 h, NR8383 was added to the 
infected REF cells and then activated with a combination of 10 ng/ml recombinant rat IFN-γ and 20 
ng/ml lipopolysaccharide (LPS). Supernatants were harvested at different time points and 
quantitatively assayed for TNF-α by enzyme-linked immunosorbent assay (ELISA; eBioscience) and 
iNOS production by a Griess assay kit (Promega; see Fig. S1A and B in the supplemental material). In 
other approaches, NR8383 was preactivated with 10 ng/ml gamma interferon (IFN-γ) and 20 ng/ml 
LPS for 24 h prior to adding them to the infected REFs (see Fig. S1C and D in the supplemental 
material), or NR8383 was mixed and incubated with the infected REFs for 24 h and then activated with 
IFN-γ and LPS (see Fig. S1E and F in the supplemental material). However, even under these 
different stimulation approaches and times, no differences between RCMV wt and the e127 mutant 
virus could be detected. To further investigate if the expression of CD200R on the macrophages was 
altered by activation of the cells, we analyzed CD200R expression by flow cytometry; however, this did 
not reveal any differences (see Fig. S2 in the supplemental material).  
In addition, we infected different cohorts of rats with this set of viruses to investigate if the presence of 
e127 correlates with lower levels of myeloid cell activity detected by production of iNOS and other 
markers in the spleen. Spleens of rats infected with either wild-type or mutant virus showed slight 
differences in iNOS and major histocompatibility complex (MHC) class II expression, but the variation 
between animals prevented a definitive conclusion as to whether inflammation was affected by the 
e127 protein. Statistically significant changes were not observed, and it is likely that e127 serves a 
  
subtle effect not evident in these assays. The role of CD200 as a negative regulator of myeloid cells 
together with the fact that CD200 orthologues are expressed by a wide range of viruses indicates that 
capture of host CD200 provides an evolutionary advantage to the virus and indicates a role in their 
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Figure 1. RCMV e127 binds CD200R on rat peritoneal macrophages. Flow cytometry shows that 
RCMV e127CD4 (A)- or rat CD200CD4 (B)-coated fluorescent beads bound rat peritoneal 
macrophages (green line) compared to rat CD4-coated control beads (purple). The specificity for the 
CD200R was shown by the complete blocking of bead binding with rat CD200R MAb (OX102) (pink 
dashed lines are indistinguishable from control beads [purple]) but not with isotype-matched control 







Figure 2 The viral RCMV e127 protein interacts with rat CD200R with equilibrium affinities and 
kinetics similar to those of the rat CD200 protein. The left panels show data for the RCMV e127, and 
the right panels show data for rat CD200. (A) The indicated concentrations (μM) of viral ligand RCMV 
e127CD4 (left) or host ligand rat CD200CD4 (right) were injected at 15 μl/min, at 37°C, through flow 
cells with 1,526 response units (RU) of CD200RCD4bio (CD200R) or 3,095 RU of CD4-biotin (control) 
immobilized. The amount of rat CD200CD4 or RCMV e127CD4 that bound at each concentration was 
calculated from the response at equilibrium in the CD200RCD4 and control flow cell, and these are 
plotted as binding curves in panel B. The inset shows SDS-PAGE analysis of the two chimeric proteins 
RCMV e127CD4 (left) and rat CD200CD4 (right) used in these studies. (B) The curved line in the main 
plots is a nonlinear curve fit of the data and corresponds to an affinity of 1.5 μM for both, the host and 
the viral ligand. Scatchard transformations to the same binding data are shown in the insets, and the 




Figure 3 Construction and characterization of recombinant viruses. (A) Construction of recombinant 
viruses following homologous recombination in REF cells. In the initially obtained mutant virus, e127 
was replaced by lacZ flanked by LoxP sites. The resultant RCMVΔe127lacZ virion DNA was 
cotransfected with Cre recombinase into REF cells to generate the RCMVΔe127 virus. All viruses 
were double-plaque purified. Recombinant viruses were analyzed by HindIII digest and Southern blot 
analysis (using a probe directed against e127 [B] or lacZ [C]). Virus growth capacities of RCMV wt, 
RCMVΔe127, and RCMVe127rev viruses were analyzed by infecting REF cells with each virus at 
either a high MOI of 5 (D) or a low MOI of 0.1 (E). 
  
Figure 4. OX2 (CD200) MAb recognizes RCMV e127 on infected cells but not the rat macrophage cell 
line NR8383. REF cells were mock infected (A) or infected with the RCMV wt (B), RCMVΔe127 (C), or 
RCMVe127rev (D) virus. (E) e127 is not expressed on infected NR8383 cells. REF cells and 
macrophages were infected at MOIs of 5 and 10, respectively. Shaded histogram, no staining; dotted 
line, avidin-fluorescein isothiocyanate (FITC); solid line, OX2-biotin followed by avidin-FITC staining 
(F). Growth analysis of RCMV wt, RCMVΔe127, and RCMVe127rev viruses using the rat macrophage 
cell line NR8383. Following macrophage infection, supernatants were harvested at the times indicated 
and titers were determined on REF cells. 
 
 
 
